Background
==========

Comparative sequence analysis is an approach proven to aid in recognition of genes and defining of their function, especially when comparing genomes of close evolutionary distance. In addition, when partial genomes are placed in a context of a well-studied and fully sequenced model organism they can greatly facilitate the understanding of the less studied organisms\' biology.

Hookworms are blood-feeding nematodes that infect one billion people causing iron deficiency anemia and retarded physical and cognitive development in children \[[@B1]\]. The two major species infecting humans are *Necator americanus*and *Ancylostoma duodenale*. The closely related hookworm species of canids, *Ancylostoma caninum*, and canines and felines, *A. ceylanicum*, are minor parasites of humans, but are important as laboratory models for hookworm infection and disease. Other hookworms infect raccoons, sheep, seals and a variety of other mammals \[[@B2]\]

Adult (Ad) hookworms inhabit the small intestine and produce eggs that pass in the feces and hatch in the soil. The first stage larva (L1) feeds on bacteria and molts twice to form the non-feeding, infective third stage (iL3). iL3 enters the host by penetrating the skin, or orally in the case of *Ancylostoma*species, molts twice, and matures to Ad in the small intestine. *A. duodenale*and *A. caninum*L3s can also infect a host, temporarily abort maturation and enter an arrested state (hypobiosis) within the host\'s somatic tissues \[[@B3]\], reactivating in response to host physiological changes such as pregnancy \[[@B4]\].

Current hookworm control strategies are limited to de-worming of infected people using anthelmintic drugs. However, rapid re-infection in endemic areas and the lack of sterile immunity necessitates repeated treatments and can in turn result in resistance. Additionally, tissue-arrested stages are relatively resilient to the effects of anthelmintics \[[@B5]\]. The Human Hookworm Vaccine Initiative is beginning clinical trials of a larval hookworm antigen, ASP-2, from *N. americanus*, as a vaccine antigen \[[@B6]\]. There is a critical need for further research to identify new vaccine and drug targets as well as to better understand hookworm biology. Lack of sequence information has been a major hindrance to hookworm molecular studies. High throughput sequencing of expressed sequence tags (ESTs; sequences derived from randomly selected cDNA clones) has proven a cost-effective tool for discovering genes \[[@B7]\]. Because the hookworm superfamily (Ancylostomatoidea) falls within nematode Clade V \[[@B8],[@B9]\], which also contains the well-studied model nematode *Caenorhabditis elegans*\[[@B10]\], predictions may be made and tested based on their close relatedness. Previous genome-based characterization of hookworms has been limited to sampling of few hundred ESTs \[[@B11]\] and molecular studies of individual genes of interest (eg. \[[@B12]\]; reviewed in \[[@B13]\]). EST approaches have also been initiated for other Strongylid parasites including *Haemonchus contortus*\[[@B14],[@B15]\] and *Nippostrongylus brasiliensis*\[[@B16]\].

In this report we describe the comparative analyses of almost 20,000 ESTs from 7 different cDNA libraries representing pre-parasitic and parasitic larval through adult stages of the hookworms *A. caninum*and *A. ceylanicum*. The dataset defined nearly 7,000 hookworm genes, including a number of putative developmentally expressed genes and candidates for further study as drug target or vaccine components.

Results
=======

Nearly 20,000 *Ancylostoma*derived ESTs were submitted to GenBank between 1999 and 2003 \[see [Additional file 1](#S1){ref-type="supplementary-material"}\]. For simplicity, the results and analysis described are presented in the same order beginning with *A. caninum*and followed by *A. ceylanicum*, except where specified.

EST acquisition and NemaGene organization
-----------------------------------------

ESTs originated from 7 cDNA libraries, representing three and two life-cycle stages respectively (Table [1](#T1){ref-type="table"}). Clustering, implemented to reduce data redundancy and improve sequence quality and length, grouped ESTs into contigs which were further organized into clusters (Table [1](#T1){ref-type="table"}), providing a non-redundant catalog of represented genes. ESTs within a contig derive from nearly identical transcripts while contigs within a cluster may arise from splice isoforms, alleles, or closely related paralogs \[[@B17]\]. Fifty-one potentially chimeric ESTs were discarded. Clusters ranged in size from a single EST to 203 and 323 for *A. caninum*and *A. ceylanicum*respectively (Figure [1](#F1){ref-type="fig"}). Most clusters for each species (72% and 55%) have ten or fewer ESTs. GC content for coding sequences was similar in the two species (44% and 48%) and consistent with other Clade V nematodes like *C. elegans*and *C. briggsae*\[[@B18]\].

###### 

*Ancylostoma*libraries sequenced and their properties

                    Nematode stage (vector or SL1 based)   ESTs Submitted   Nucleotides (million)   Mean read length (bp)   StDev
  ----------------- -------------------------------------- ---------------- ----------------------- ----------------------- -------
  *A. caninum*      Infective L3 (UniZap)                  5,679            2,632                   358                     109
                    Tissue arrested L3 (SL1)               820              0,318                   344                     151
                    Serum stimulated L3 (pAMP)             2,832            1,273                   441                     150
                    Overall                                9,331            4,223                   381                     137
                                                                                                                            
                    Contigs -- 5,484 (4,020 clusters)                                               502                     168
                                                                                                                            
  *A. ceylanicum*   Infective L3 (λZAP II)                 3,359            2,021                   500                     127
                    Infective L3 (SL1)                     3,306            1,550                   400                     143
                    Adult (M1 SL1)                         629              0,319                   460                     134
                    Adult (M2 SL1)                         480              0,255                   467                     131
                    Adult (λZAP II)                        2,817            1,646                   500                     139
                    Overall                                10,591           5,791                   465                     135
                                                                                                                            
                    Contigs -- 4,953 (3,369 clusters)                                               572                     179

![*Ancylostoma*NemaGene v2.0 clustering showing the distribution of ESTs by cluster size. For example, there are three *A. caninum*cluster of size 22 containing a sum of 66 ESTs and there were eight *A. ceylanicum*clusters of size 22 containing a sum of 176 ESTs. Cluster size (x-axis) is shown to scale for 1--75 members, with the size of larger clusters indicated.](1471-2164-6-58-1){#F1}

The number of clusters may overestimate gene discovery, as one gene may be represented by multiple non-overlapping clusters (fragmentation). By using *C. elegans*as a reference genome (19,522 genes; \[[@B10]\]) and discounting for fragmentation calculated as 4.5% and 6.5 % respectively \[[@B17]\], the estimated gene numbers were reduced to 3,840 for *A. caninum*and 3,149 for *A. ceylanicum*giving a gene discovery rate of 41% (3,840 × 100/9,283) and 30% (3,149 × 100/10,588). These numbers also indicate 20% and 16% representation of all genes for each species respectively. The number of genes in common for more stage-specific *Ancylostoma*libraries analysed was as low as 9% and 11% (Figure [2](#F2){ref-type="fig"}). This may reflect the EST sample size or stage-specific expression, as will be discussed. In either case, the results clearly show the advantage gained for gene discovery in *Ancylostoma*by including diverse life stages in the analysis.

![Venn diagram of *A. caninum*(A) and *A. ceylanicum*(B) clusters, based on stage of origin of each cluster\'s EST members. The majority of clusters are represented by only one stage in this investigation, though greater depth of sampling would likely increase representation by multiple stages.](1471-2164-6-58-2){#F2}

Functional classification based on Gene Ontology and KEGG assignments
---------------------------------------------------------------------

Thirty-four percent of *A. caninum*and 54% of *A. ceylanicum*clusters align to InterPro domains and 21% and 36% map to Gene Ontology (GO) respectively. Following this same pattern, *A. caninum*also had fewer BLAST matches (see below). Seven of the ten most abundantly represented InterPro domains were common to both species (Table [2](#T2){ref-type="table"}). GO representation is shown by biological process, cellular component, and molecular function (Table [3](#T3){ref-type="table"}). Among the most common GO categories are protein metabolism (GO:0019538) and catalytic activity (GO:0003824).

###### 

Most abundantly represented protein domains in *A. caninum*and *A. ceylanicum*datasets

  Species           InterPro ID   Clusters \#   Domain descriptor
  ----------------- ------------- ------------- --------------------------------------------------
  *A. caninum*                                  
                    IPR001230     141           Prenyl group, CAAX box, attachment site
                    IPR001687     66            ATP/GTP-binding site motif A (P-loop)
                    IPR000694     62            Proline-rich region
                    IPR001472     51            Bipartite nuclear localization signal
                    IPR000345     29            Cytochrome c heme-binding site
                    IPR001283     25            Allergen V5/Tpx-1 related
                    IPR002048     24            Calcium-binding EF-hand
                    IPR000504     21            RNA-binding region RNP-1 (RNA recognition motif)
                    IPR000719     19            Protein kinase
                    IPR007087     17            Zn-finger, C2H2 type
  *A. ceylanicum*                               
                    IPR000694     214           Proline-rich region
                    IPR001230     153           Prenyl group, CAAX box, attachment site
                    IPR001687     125           ATP/GTP-binding site motif A (P-loop)
                    IPR000345     50            Cytochrome c heme-binding site
                    IPR006209     48            EGF-like domain
                    IPR000504     37            RNA-binding region RNP-1 (RNA recognition motif)
                    IPR001283     34            Allergen V5/Tpx-1 related
                    IPR001472     32            Bipartite nuclear localization signal
                    IPR000169     32            Eukaryotic thiol (cysteine) protease
                    IPR001534     27            Transthyretin-like

###### 

GO mappings for *A. caninum*and *A. ceylanicum*clusters

                                                                         *A. caninum*   *A. ceylanicum*          
  ----------------------------------- ---------------------------------- -------------- ----------------- ------ -------
  biological process                                                                                             
   cellular process                                                      192            4.80              238    4.36
    cell communication                                                   62             1.55              66     1.21
    cell motility                                                        1              0.03              0      0.00
    cell death                                                           1              0.03              1      0.02
    cell growth and/or maintaince     140                                3.50           180               3.30   
                                      transport                          119            2.98              153    2.80
                                      cell organization and biogenesis   21             0.53              32     0.59
                                      cell proliferation                 4              0.10              6      0.11
                                      cell homeostasis                   1              0.03              4      0.07
   physiological process                                                 579            14.48             785    14.38
    response to endogenous stimulus   1                                  0.03           5                 0.09   
    response to external stimulus     12                                 0.30           16                0.29   
    response to stress                                                   8              0.20              14     0.26
    death                                                                1              0.03              1      0.02
    metabolism                                                           466            11.65             653    11.96
    hemostasis                                                           1              0.03              0      0.00
    homeostasis                                                          3              0.08              4      0.07
    secretion                                                            0              0.00              1      0.02
   development                                                           11             0.28              18     0.33
                                                                                                                 
  cellular component                                                                                             
   cell                                                                  327            8.18              385    7.05
    intracellular                                                        212            5.30              277    5.08
                                      cytoplasm                          166            4.15              181    3.32
                                      nucleus                            45             1.13              84     1.54
                                      ribonucleoprotein complex          102            2.55              102    1.87
                                      respiratory chain complex          4              0.10              5      0.09
                                      chromosome                         8              0.20              13     0.24
                                      thylakoid                          0              0.00              1      0.02
    membrane                                                             146            3.65              146    2.67
   extracellular                                                         33             0.83              50     0.92
   Unlocalized                                                           1              0.03              7      0.13
                                                                                                                 
  molecular function                                                                                             
   binding                                                               323            8.08              521    9.55
    carbohydrate binding                                                 6              0.15              20     0.37
    lipid binding                                                        6              0.15              12     0.22
    metal ion binding                                                    56             1.40              72     1.32
    nucleic acid binding                                                 109            2.73              201    3.68
    nucleotide binding                                                   133            3.33              214    3.92
    protein binding                                                      11             0.28              22     0.40
   apoptosis regulator activity       1                                  0.03           1                 0.02   
   chaperone activity                                                    5              0.13              10     0.18
   cell adhesion molecule activity    2                                  0.05           1                 0.02   
   catalytic activity                                                    293            7.33              445    8.15
   enzyme regulator activity          24                                 0.60           35                0.64   
   molecular function unknown         38                                 0.95           46                0.84   
   motor activity                                                        3              0.08              12     0.22
   signal transducer activity         55                                 1.38           61                1.12   
   structural molecule activity       107                                2.68           127               2.33   
   transcription regulator activity   19                                 0.48           33                0.60   
   translation regulator activity     14                                 0.35           17                0.31   
   transporter activity                                                  128            3.20              180    3.30

Within *Ancylostoma spp*. clusters that had extracellular mappings, 70% and 56% respectively were in the category of Allergen V5/Tpx-1 proteins (IPR001283) related to the secreted venom proteins from hymenopteran insects (Table [2](#T2){ref-type="table"}). The *Ancylostoma*secreted proteins (ASPs) belong to this large gene family \[[@B19]\], members of which been shown to play roles in host-parasite interactions for both mammalian \[[@B20],[@B21]\] and plant parasitic nematodes \[[@B22]\], and to induce protective responses \[[@B6]\]. ASP-1 is one of the major proteins secreted by serum-stimulated *A. caninum*iL3 \[[@B12]\]. In addition, four *A. ceylanicum*clusters were classified in extracellular matrix (GO:0005578) as tissue inhibitor of metalloprotease (TIMP) domain proteins. A TIMP homolog is reported as the most abundant protein in adult hookworm excretory/secretory products and may inhibit host metalloproteases \[[@B23]\].

Ten % and 15% unique clusters for *A. caninum*and *A. ceylanicum*respectively, mapped to 89 metabolic pathways grouped in 11 categories (Table [4](#T4){ref-type="table"}). Complete listings and graphical representations of the KEGG mappings are available at <http://www.nematode.net>. Pathways well represented by both species include glycolysis/gluconeogenesis, citrate cycle, oxidative phosphorylation and fatty acid biosynthesis and metabolism. KEGG analysis (Table [4](#T4){ref-type="table"}) also suggests specific biochemical differences among *Ancylostoma*stages. For example, while serum stimulated L3-specific clusters make up to 27% of all AC clusters, they account for 40% of all KEGG pathway mappings. In contrast, iL3-specific clusters that account for 55% of all AC clusters make-up only 38% of KEGG pathway mappings. It is unclear whether the predominance of enzyme mappings from the ssL3 stage versus iL3 stage is indicative of greater metabolic activity, greater metabolic complexity, differences in library construction methods, or other differences.

###### 

Kegg Biochemical pathway mappings for *A. caninum*and *A. ceylanicum*clusters

                                                              AC   Clusters per library       AE   Clusters per library        Total \# of enzymes in KEGG                      
  ----------------------------------------------------------- ---- ---------------------- --- ---- ---------------------- ---- ----------------------------- ---- ---- --- ---- ----
  1\. Carbohydrate metabolism                                                                                                                                                   
   1.1 Glycolysis / Gluconeogenesis                           23   13                     0   5    5                      22   25                            10   11   4   23   40
   1.2 Citrate cycle (TCA cycle)                              17   8                      0   4    5                      16   15                            4    8    3   15   23
   1.3 Pentose phosphate pathway                              9    3                      0   4    2                      9    12                            5    3    4   8    34
   1.4 Pentose and glucuronate interconversions               8    3                      0   3    2                      9    9                             5    4    0   8    53
   1.5 Fructose and mannose metabolism                        14   6                      0   4    4                      15   20                            7    11   2   15   61
   1.6 Galactose metabolism                                   10   4                      0   4    2                      8    12                            6    5    1   12   37
   1.7 Ascorbate and aldarate metabolism                      7    4                      0   2    1                      4    5                             5    0    0   4    29
   1.8 Pyruvate metabolism                                    25   11                     0   11   3                      23   27                            8    17   2   26   67
   1.9 Glyoxylate and dicarboxylate metabolism                13   6                      0   5    2                      14   9                             1    5    3   17   58
   1.10 Propanoate metabolism                                 22   7                      1   10   4                      20   25                            11   8    6   22   46
   1.11 Butanoate metabolism                                  22   9                      1   7    5                      23   29                            14   14   1   26   52
   1.12 C5-Branched dibasic acid metabolism                   4    3                      0   1    0                      2    2                             1    0    1   1    20
   1.13 Inositol metabolism                                   6    2                      0   1    3                      4    7                             2    3    2   4    5
  2\. Energy metabolism                                                                                                                                                         
   2.1 Oxidative phosphorylation                              24   7                      0   6    11                     11   33                            10   14   9   13   14
   2.2 ATP synthesis                                          8    2                      0   3    3                      1    11                            4    3    4   1    1
   2.4 Carbon fixation                                        11   3                      0   3    5                      11   11                            3    5    3   13   23
   2.5 Reductive carboxylate cycle (CO2 fixation)             12   7                      0   1    4                      8    9                             2    4    3   7    13
   2.6 Methane metabolism                                     6    4                      0   0    2                      5    6                             0    4    2   6    26
   2.7 Nitrogen metabolism                                    11   2                      0   5    4                      14   12                            5    5    2   15   64
   2.8 Sulfur metabolism                                      5    1                      0   1    3                      9    6                             3    1    2   9    30
  3\. Lipid metabolism                                                                                                                                                          
   3.1 Fatty acid biosynthesis (path 1)                       6    2                      0   3    1                      11   7                             3    3    1   6    14
   3.2 Fatty acid biosynthesis (path 2)                       8    2                      0   5    1                      6    6                             3    2    1   5    8
   3.3 Fatty acid metabolism                                  14   6                      1   6    1                      17   21                            13   7    1   16   28
   3.4 Synthesis and degradation of ketone bodies             2    0                      0   1    1                      2    8                             4    3    1   3    6
   3.5 Sterol biosynthesis                                    4    1                      1   2    0                      4    4                             2    2    0   9    35
   3.6 Bile acid biosynthesis                                 11   7                      1   2    1                      11   11                            6    4    1   10   27
   3.8 Androgen and estrogen metabolism                       7    5                      0   2    0                      9    7                             4    3    0   8    26
  4\. Nucleotide metabolism                                                                                                                                                     
   4.1 Purine metabolism                                      27   11                     0   11   5                      28   32                            14   11   7   32   99
   4.2 Pyrimidine metabolism                                  16   8                      1   5    2                      15   22                            9    12   1   22   61
   4.3 Nucleotide sugars metabolism                           6    4                      0   0    2                      3    4                             2    2    0   4    30
  5\. Amino acid metabolism                                                                                                                                                     
   5.1 Glutamate metabolism                                   11   3                      0   5    3                      14   16                            8    7    1   18   36
   5.2 Alanine and aspartate metabolism                       14   1                      0   8    5                      15   14                            5    6    3   15   38
   5.3 Glycine, serine and threonine metabolism               19   7                      0   9    3                      14   21                            8    10   3   24   56
   5.4 Methionine metabolism                                  6    1                      0   4    1                      9    6                             5    1    0   8    24
   5.5 Cysteine metabolism                                    8    2                      0   2    4                      11   7                             5    2    0   9    23
   5.6 Valine, leucine and isoleucine degradation             16   3                      1   8    4                      16   22                            11   6    5   18   32
   5.7 Valine, leucine and isoleucine biosynthesis            7    1                      0   4    2                      7    9                             6    2    1   8    15
   5.8 Lysine biosynthesis                                    11   1                      0   6    4                      10   9                             4    3    2   8    31
   5.9 Lysine degradation                                     19   8                      0   8    3                      14   19                            12   6    1   17   47
   5.10 Arginine and proline metabolism                       18   4                      0   8    6                      20   22                            11   7    4   20   71
   5.11 Histidine metabolism                                  10   4                      0   4    2                      8    10                            5    4    1   8    39
   5.12 Tyrosine metabolism                                   18   8                      0   7    3                      19   19                            11   5    3   19   67
   5.13 Phenylalanine metabolism                              13   5                      0   3    5                      11   14                            7    6    1   12   40
   5.14 Tryptophan metabolism                                 17   8                      0   8    1                      15   22                            16   4    2   18   61
   5.15 Phenylalanine, tyrosine and tryptophan biosynthesis   5    1                      0   2    2                      6    4                             2    0    2   7    31
   5.16 Urea cycle and metabolism of amino groups             10   1                      0   5    4                      14   10                            2    6    2   11   35
  6\. Metabolism of other amino acids                                                                                                                                           
   6.1 beta-Alanine metabolism                                14   4                      1   7    2                      13   11                            8    1    2   10   32
   6.2 Taurine and hypotaurine metabolism                     1    0                      0   0    1                      1    2                             2    0    0   3    14
   6.3 Aminophosphonate metabolism                            4    0                      0   3    1                      3    5                             2    3    0   5    15
   6.4 Selenoamino acid metabolism                            7    0                      0   4    3                      12   12                            6    4    2   15   22
   6.5 Cyanoamino acid metabolism                             2    1                      0   1    0                      1    7                             5    1    1   6    19
   6.6 D-Glutamine and D-glutamate metabolism                 2    0                      0   1    1                      2    2                             1    0    1   2    12
   6.7 D-Arginine and D-ornithine metabolism                  3    1                      0   0    2                      2    3                             0    2    1   2    10
   6.9 Glutathione metabolism                                 5    1                      0   0    4                      4    9                             5    3    1   6    27
  7\. Metabolism of complex carbohydrates                                                                                                                                       
   7.1 Starch and sucrose metabolism                          18   2                      0   13   3                      18   20                            13   6    1   20   75
   7.2 N-Glycans biosynthesis                                 7    4                      0   1    2                      7    7                             2    4    1   9    27
   7.3 O-Glycans biosynthesis                                 3    1                      0   1    1                      2    6                             5    1    0   3    8
   7.5 Aminosugars metabolism                                 6    3                      0   2    1                      6    10                            5    5    0   10   39
   7.8 Glycosaminoglycan degradation                          1    1                      0   0    0                      1    1                             1    0    0   1    13
   7.9 Chondroitin / Heparan sulfate biosynthesis             5    3                      0   1    1                      4    6                             2    4    0   4    18
   7.10 Keratan sulfate biosynthesis                          1    0                      0   1    0                      1    2                             1    1    0   1    6
  8\. Metabolism og complex lipids                                                                                                                                              
   8.1 Glycerolipid metabolism                                24   10                     0   9    5                      22   25                            10   13   2   22   80
   8.3 Inositol phosphate metabolism                          8    4                      0   4    0                      4    8                             5    2    1   3    25
   8.4 Sphingophospholipid biosynthesis                       1    1                      0   0    0                      1    2                             1    1    0   2    8
   8.5 Phospholipid degradation                               3    2                      0   0    1                      3    1                             1    0    0   1    11
   8.6 Sphingoglycolipid metabolism                           11   1                      1   9    0                      7    10                            8    2    0   4    20
   8.9 Globoside metabolism                                   2    1                      0   1    0                      2    2                             1    1    0   1    12
   8.11 Prostaglandin and leukotriene metabolism              8    2                      0   1    5                      8    7                             4    3    0   6    19
  9\. Metabolism of cofactors and vitamins                                                                                                                                      
   9.2 Riboflavin metabolism                                  4    1                      0   3    0                      2    2                             2    0    0   2    13
   9.3 Vitamin B6 metabolism                                  6    4                      0   1    1                      3    6                             4    1    1   5    23
   9.4 Nicotinate and nicotinamide metabolism                 11   2                      0   7    2                      7    15                            8    7    0   7    32
   9.5 Pantothenate and CoA biosynthesis                      8    2                      0   4    2                      9    8                             6    2    0   7    27
   9.7 Folate biosynthesis                                    5    2                      1   0    2                      5    6                             1    4    1   5    25
   9.8 One carbon pool by folate                              5    3                      0   2    0                      10   7                             3    3    1   8    24
   9.10 Porphyrin and chlorophyll metabolism                  18   4                      0   10   4                      12   27                            15   8    4   13   56
   9.11 Ubiquinone biosynthesis                               19   10                     0   5    4                      13   28                            11   14   3   14   22
  10\. Biosynthesis of secondary metabolites                                                                                                                                    
   10.1 Terpenoid biosynthesis                                0    0                      0   0    0                      0    2                             0    2    0   4    12
   10.3 Flavonoids, stilbene and lignin biosynthesis          6    3                      0   1    2                      7    8                             5    3    0   7    39
   10.4 Alkaloid biosynthesis I                               5    2                      0   3    0                      6    3                             3    0    0   5    36
   10.8 Streptomycin biosynthesis                             2    0                      0   2    0                      3    4                             2    1    1   4    14
   10.9 Erythromycin biosynthesis                             2    0                      0   2    0                      3    3                             2    1    0   3    6
  11\. Biodegradation of xenobiotics                                                                                                                                            
   11.4 Nitrobenzene degradation                              4    1                      0   3    0                      5    4                             2    1    1   3    17
   11.9 Tetrachloroethene degradation                         6    4                      0   1    1                      3    2                             2    0    0   3    5
   11.10 Styrene degradation                                  4    2                      0   2    0                      3    6                             5    0    1   5    18
   11.1 gamma-Hexachlorocyclohexane degradation               6    3                      0   3    0                      5    5                             3    2    0   4    12
   11.1 Fluorene degradation                                  3    1                      0   2    0                      4    2                             2    0    0   2    13
   11.2 Benzoate degradation via CoA ligation                 22   8                      1   10   3                      18   25                            14   10   1   18   38
   11.2 Benzoate degradation via hydroxylation                7    2                      0   5    0                      7    5                             4    1    0   5    45

^a^*A. caninum*-- 839 multiple and 786 unique mappings; *A. ceylanicum*-- 957 multiple and 840 unique mappings. ^b^Cluster, ^c^Enzymes

Homologs in other organisms, orthologs within *Ancylostoma spp*. and estimates of selective pressure
----------------------------------------------------------------------------------------------------

Within *A. ceylanicum*clusters, 83% had homology to proteins from other organisms as compared to only 66% for *A. caninum*(Figure [3](#F3){ref-type="fig"}). To investigate why contigs from closely related species would show a difference in identified homologies, we compared sequence lengths and the open reading frame (ORF) lengths of contigs with and without homologies in both species. EST lengths and contig lengths, respectively, were shorter for *A. caninum*(410 and 549 nucleotides) than for *A. ceylanicum*(490 and 637 nucleotides). The differences were even more striking for ORFs (Figure [4](#F4){ref-type="fig"}). Hence, *A. caninum*contigs very likely identify fewer homologs because these sequences are shorter, contain smaller ORFs, and probably include more 3\' UTR versus the superior quality dataset from *A. ceylanicum*. Most likely, differences in library construction and sampling rather than intrinsic differences between the species explain this discrepancy. Accounting for such differences is important as it keeps analysis focused upon interesting features of the dataset related to the organisms\' biology rather than artifactual differences arising from data collection.

![Venn diagram showing distribution of *A. caninum*(A) and *A. ceylanicum*(B) cluster BLAST matches by database. Amino acid level homologies (≥ e-05) were identified to non-*Ancylostoma*sequences for 65.8% (2,646/4,020) of *A. caninum*and 83.1% (2,801/3,369) of *A. ceylanicum*clusters. Databases used are: for *C. elegans*, Wormpep v.97 and mitochondrial protein sequences; for other nematodes, all GenBank nucleotide data for nematodes except *C. elegans*and *Ancylostoma*; for non-nematodes, nrGenBank (3/20/2003) with all nematode sequences removed.](1471-2164-6-58-3){#F3}

![Distribution of *A. caninum*and *A. ceylanicum*contigs with and without database amino acid level homology by size of the longest predicted open reading frame (ORF).](1471-2164-6-58-4){#F4}

The distribution of identified homologs (Figure [3](#F3){ref-type="fig"}) was consistent with earlier observations \[[@B17]\]. Besides *C. elegans*, one of the more informative nematode datasets for this study is a collection of 4,780 ESTs from the human hookworm *Necator americanus*to which homologies were commonly found (42% and 38% respectively). Within *Ancylostoma*itself homologies were common with 34% of total *A. caninum*clusters matching the *A. ceylanicum*dataset and 44% of total *A. ceylanicum*clusters matching *A. caninum*. Searching for putative orthologs between all *A. caninum*and *A. ceylanicum*contigs resulted in 1,304 reciprocal best TBLASTX hits. The ortholog pair members were very similar in GC composition (46% and 47%) and the average length of alignment was 327 bp. All ortholog pairs (574) were under purifying selection (dN/dS \< 1; Figure [5](#F5){ref-type="fig"}) and the average dS was 0.65 ± 0.83 and dN was 0.11 ± 0.2. The average dN/dS ratio (\~0.17) is higher than that reported for *C. briggsae/C. elegans*(\~0.06; \[[@B18]\]), and closer to that for mouse/human (0.115; \[[@B24]\]), indicating that the levels of purifying selection are somewhat different. In addition, to examine if this purifying selection is more frequently detected in genes with essential function, we cross-referenced the *C. elegans*genes matched by *Ancylostoma*orthologs with a list of *C. elegans*genes with available RNA interference (RNAi) information (<http://www.wormbase.org>; eg. \[[@B25]\]). Of the 67% of the orthologous genes matching *C. elegans*genes with available RNAi data, 45% had an observable phenotype after transcript knock-down. A vast majority of the observed phenotypes were severe (88% sterility and embryonic lethality). *Ancylostoma*orthologs matching *C. elegans*genes that had phenotypes showed a somewhat lower dN/dS ratio than those matching genes that remained wild type after RNAi treatment, though the difference was not statistically significant at P \< 0.05 (0.09 vs. 0.14; sign. diff. at P \< 0.2).

![Distribution of dN/dS ratios among *Ancylostoma*ortholog pairs. dN and dS are the rates of nonsynonymous and synonymous amino acid substitutions, respectively.](1471-2164-6-58-5){#F5}

In a 4-way comparison of orthologs in *C. elegans, C. briggsae, A. caninum*, and *A. ceylanicum*, the phylogenetic distance between *A. caninum*and *A. ceylanicum*is almost identical to that between *C. elegans*and *C. briggsae*and the distance between the two genera is just over four times the within genera distance (Figure [6](#F6){ref-type="fig"}). Average branch lengths for the set of 452 orthologous proteins did not show a significant difference in relative rate of molecular change. Maximum likelihood trees \[[@B26]\] were constructed for each 4-way ortholog and relative branch lengths compared between *Ancylostoma spp*. for both the protein and nucleotide sequences. For protein sequences, 109 trees had equal branch lengths for the hookworm species while 175 trees had longer *A. caninum*branches and 168 had longer *A. ceylanicum*branches. To look for differences between genes in the *Ancylostoma*species, we constructed a distribution of branch length differences between each of the sister species pairs in our tree. Because some genes may be rapidly evolving in all nematode lineages we evaluated a subset of the trees where the difference in branch lengths between *C. briggsae*and *C. elegans*were less than one standard deviation from the mean but which had significantly different branch lengths in the two *Ancylostoma*species. This final dataset had 23 genes with significantly longer branch lengths in *A. ceylanicum*and 16 in *A. caninum*(1 SD, P \< 0.05). However the set did not show any significant bias towards either species (p \< 0.34, sign test). This suggests there is no significant rate difference in protein evolution between the two hookworms, although some of these genes are relatively rapidly evolving. Repeating the analysis for nucleotide sequences we find marginally significant differences (p \< 0.08; sign test).

![Relative distance based upon protein maximum likelihood. *A. ceylanicum*to *A. cananum*distance is similar to *C. elegans*to *C. briggsae*distance. *Ancylostoma*to *Caenorhabditis*distance for any species is 4.3X the *Ancylostoma*to *Ancylostoma*distance and 4.1X the *Caenorhabditis*to *Caenorhabditis*distance. The length of each line segment is proportional to the calculated branch length between the species.](1471-2164-6-58-6){#F6}

Using the *C. elegans*genome to interpret hookworm sequences
------------------------------------------------------------

As expected, the *C. elegans*genome provides the best source of information for interpreting hookworm sequences as a majority of *A. caninum*and *A*. *ceylanicum*clusters with BLAST homologies outside *Ancylostoma*had *C. elegans*homologs (Figure [3](#F3){ref-type="fig"}; 25 most conserved nematode genes between each *Ancylostoma*species and *C. elegans*are available online; \[see [Additional file 2](#S2){ref-type="supplementary-material"}\]). Furthermore, *C. elegans*orthologs of hookworm genes with available RNAi or other data provide information that may be relevant to understanding the role of the parasite genes. Of all the *Ancylostoma*clusters with *C. elegans*homology, 97% and 92% matched *C. elegans*genes with available RNA interference knock-down information <http://www.wormbase.org>, and in turn 33% and 37% of these *C. elegans*genes produce RNAi phenotypes (versus a rate of only \~15% phenotypes for all *C. elegans*genes). Phenotype classification \[see [Additional file 3](#S3){ref-type="supplementary-material"}\] showed that *C. elegans*genes with expressed *Ancylostoma*homologs were somewhat more likely to have severe phenotypes \[[@B17]\]. Hence, certain genes in the *Ancylostoma*datasets encode proteins if disabled may disrupt survival of the parasite. Some examples include abundant clusters (AC00023.cl, AE01104.cl; Table [5](#T5){ref-type="table"} and Table [6](#T6){ref-type="table"}). A group of particular interest is proteins that are required for nematode survival and lack strong homologies outside of the phyla (nematode-specific), since these targets could provide for nematode control without toxicities to the host or other non-target organisms. Of the *Ancylostoma*nematode-specific clusters (Figure [3](#F3){ref-type="fig"}), 85 and 91 respectively had *C. elegans*matches with RNAi phenotypes. Among these, AC04398.cl and AE00474.cl matched hypothetical protein F42A8.1 (1e-65, 2e-76 respectively), a gene without a mammalian homolog yet likely involved in multiple developmental processes based on observed mutant phenotypes \[[@B25]\]. Homologs are found in at least 13 nematode species to date including free-living species (3), and parasites of mammals (8) and plants (1). Further analysis will identify additional genes which warrant detailed investigation.

###### 

The most abundantly represented transcripts in the *A. caninum*cDNA libraries

                                      non-redundant GenBank                                                                  
  ------------ ----- ----- ---- ----- -------------------------------------------------------------- ----------- ----------- ----------------
  AC00932.cl   203   186   0    17    *Ancylostoma duodenale*cytochrome oxidase subunit I            CAD10437    2e -- 304   C06G4.2b
  AC00471.cl   120   2     0    118   *C. elegans*CMP-sialic acid transporter                        O02345      2e -- 83    ZK896.9^b^
  AC00048.cl   114   100   11   3     *C. elegans*hsp-12.6 alpha-B-crystallin                        Q20165      6e -- 40    F38E11.2^b^
  AC01032.cl   104   104   0    0     *Ancylostoma duodenale*cytochrome oxidase subunit II           AAL50814    1e -- 09    \-
  AC01031.cl   93    90    0    3     *Ancylostoma duodenale*cytochrome oxidase subunit III          CAD10435    2e -- 143   \-
  AC00807.cl   69    4     2    63    *Necator americanus*ancylostoma secreted protein 1 precursor   AAD13340    3e -- 28    F33A8.2
  AC00205.cl   65    51    1    13    *Ancylostoma duodenale*COX2, cytochrome c oxidase subunit II   NP_579953   4e -- 125   F26E4.12
  AC00967.cl   54    9     0    45    *Ancylostoma ceylanicum*cathepsin D-like aspartic protease     AAO22152    8e -- 174   R12H7.2
  AC00134.cl   44    44    0    0     *C. elegans*putative protein, nematode specific                NP_497272   9e -- 53    K02F3.9^b^
  AC01029.cl   39    37    2    0     *C. elegans*stress associated endoplasmic reticulum protein    NP_510604   9e -- 37    F59F4.2^b^
  AC00137.cl   38    37    0    1     *C. elegans*RNA recognition motif                              CAB03222    4e -- 35    R06C1.4^b^
  AC00023.cl   38    36    0    2     *C. elegans*rpl-2 Ribosomal Proteins L2                        Q9XVF7      3e -- 148   B0250.1^b^
  AC00060.cl   36    36    0    0     *Ancylostoma caninum*secreted protein ASP-2 precursor          AAC35986    2e -- 134   F11C7.3b
  AC01400.cl   32    1     0    31    *C. elegans*ham-2 zinc finger protein                          NP_508781   1e -- 20    C07A12.1^b^
  AC00976.cl   32    29    0    3     *Tetrahymena pigmentosa*metallothionein MT-2                   AAL87687    6e -- 12    K11G9.6
  AC00193.cl   31    7     0    24    *Pisum sativum*putative senescence-associated protein          BAB33421    2e -- 61    F58H1.7
  AC00931.cl   29    6     0    23    novel                                                          \-          \-          \-
  AC00079.cl   28    25    2    1     *Ostertagia ostertagi*unknown protein                          AAC08432    8e -- 06    \-
  AC00980.cl   27    11    0    16    *C. elegans*Glycerol kinase                                    AAA79749    8e -- 70    R11F4.1^b^
  AC00971.cl   26    9     0    17    *C. elegans*rpl-1 Ribosomal Protein Large subunit              NP_491061   5e -- 116   Y71F9AL.13a^b^
  AC01023.cl   25    22    2    1     *Ostertagia ostertagi*putative ES protein F7                   CAD20464    9e -- 87    F02A9.2
  AC00913.cl   25    6     17   2     *C. elegans*ribosomal protein L37                              O62388      2e -- 50    W01D2.1^b^
  AC02930.cl   24    0     0    24    *C. elegans*calponin-like protein                              NP_504712   4e -- 119   T25F10.6^b^
  AC00252.cl   24    12    12   0     *C. elegans*rpl-43                                             CAB54440    4e -- 49    Y48B6A.2^b^
  AC01020.cl   23    20    3    0     *C. elegans rps-15*Ribosomal Protein Small subunit RPS-15      NP_492384   1e -- 88    F36A2.6^b^

^a^SW/TR is Swiss-prot and TrEMBL Proteinknowledgebase <http://us.expasy.org/sprot/>.

^b^*C. elegans*homolog has higher probability match than the best GenBank descriptor.

###### 

The most abundantly represented transcripts in the *A. ceylanicum*cDNA libraries

                                 non-redundant GenBank                                                                      
  ------------ ----- ----- ----- ------------------------------------------------------------------ ----------- ----------- ---------------
  AE00908.cl   323   320   3     *C. elegans*stress associated endoplasmic reticulum protein        NP_510604   9e -- 37    F59F4.2^b^
  AE00787.cl   205   205   0     *C. elegans*hsp-12.6 alpha-B-crystallin                            Q20165      7e -- 39    F38E11.2^b^
  AE01104.cl   155   155   0     *C. elegans*microsomal signal peptidase 25 kDa subunit             Q9XWW1      8e -- 80    Y37D8A.10^b^
  AE00463.cl   119   118   1     *C. elegans*dlc-1 dynein light chain (10.3 kD)                     NP_498422   9e -- 56    T26A5.9^b^
  AE00121.cl   110   0     110   *C. elegans*vit-3 Vitellogenin 3 precursor                         NP_508613   7e -- 121   F59D8.1^b^
  AE00890.cl   84    84    0     *C. elegans*spp-4 SaPosin-like Protein family                      NP_509237   5e -- 16    T08A9.8^b^
  AE00065.cl   84    84    0     *C. elegans*putative endoplasmic reticulum protein                 NP_508656   1e -- 35    F47B7.1^b^
  AE00360.cl   74    74    0     novel                                                              \-          \-          \-
  AE00048.cl   72    72    0     *C. elegans*rpl-29 60S ribosomal protein L29                       NP_502671   6e -- 25    B0513.3^b^
  AE00003.cl   70    3     67    novel                                                              \-          \-          \-
  AE01410.cl   63    60    3     *Ostertagia ostertagi*putative ES protein F7                       CAD20464    3e -- 86    F02A9.2
  AE00056.cl   62    56    6     *C. elegans*hypothetical protein                                   AAK77617    5e -- 39    M01H9.3a^b^
  AE00464.cl   61    61    0     novel                                                              \-          \-          \-
  AE00227.cl   59    0     59    *Zea mays*extensin-like protein                                    S49915      2e -- 31    ZK84.1
  AE00746.cl   54    0     54    *C. elegans*protein contains chitin binding peritrophin-A domain   AAA19083    3e -- 54    B0280.5^b^
  AE00750.cl   50    36    14    *C. elegans*far-7 fatty Acid/Retinol binding protein               NP_493708   7e -- 45    K01A2.2a^b^
  AE00072.cl   47    0     47    *Beta vulgaris*chitinase                                           S51939      6e -- 12    C34D4.11
  AE00591.cl   45    45    0     *C. elegans*hypothetical protein                                   AAF99918    7e -- 26    F29B9.11^b^
  AE01221.cl   44    44    0     *Volvox carteri*hydroxyproline-rich glycoprotein DZ-HRGP           CAB62280    1e -- 29    Y59A8B.19
  AE01407.cl   41    41    0     *C. elegans*elt-3 GATA-binding transcription factor like           CAA93510    5e -- 18    K02B9.4^b^
  AE00033.cl   41    0     41    *Nippostrongylus brasiliensis*hsp-20 Nbhsp20                       CAA50655    8e -- 56    T27E4.3
  AE01361.cl   40    39    1     *C. elegans*ICD-1 inhibitor of cell death                          AAA68776    1e -- 75    C56C10.8^b^
  AE00322.cl   39    37    2     *C. elegans*hypothetical protein                                   CAB54416    7e -- 28    Y38E10A.24^b^
  AE00536.cl   36    34    2     *Homo sapiens*unnamed protein product                              BAB71316    4e -- 134   F25B5.4a
  AE00503.cl   35    13    22    *C. elegans*eft-3 elongation factor 1-alpha                        NP_498520   3e -- 283   F31E3.5^b^

^a^SW/TR is Swiss-prot and TrEMBL Proteinknowledgebase <http://us.expasy.org/sprot/>.

^b^*C. elegans*homolog has higher probability match than the best GenBank descriptor.

Repeating the analysis in Stein et al. \[[@B18]\] indicates that 6--7% of *C. elegans*and *C. briggsae*proteins are candidate \"orphans\", lacking homologs outside of the species. We examined whether these genes are truly orphans that have arisen in a *Caenorhabditis*sub-lineage or are instead genes present in an ancestral nematode that have been lost or evolved beyond recognition in one species. Of candidate orphan proteins, ten from *C. elegans*(Table [7](#T7){ref-type="table"}) and 27 from *C. briggsae*\[see [Additional file 4](#S4){ref-type="supplementary-material"}\] match *A. caninum*and/or *A. ceylanicum*clusters, with three and eight, respectively, having matches in both species. Most of the *C. elegans*orphans are hypothetical proteins of unknown function though some had functional information from InterPro domains (R10E9.3) or mutant phenotypes (ZK686.1). Therefore, at least a portion of the genes identified in either *C. elegans*or *C. briggsae*as \"orphans\" are actually ancestral nematode genes with homologs found in other clade V species and further clade V sequencing will likely reveal more such cases.

###### 

*C. elegans*candidate orphans (1,358 out of 21,437) matching *Ancylostoma*clusters

  *C. elegans*gene^a^   Descriptor                                *Ancylostoma*cluster id^b^   ESTs *per*cluster   E-value    C. elegans *gene*length (aa)   Matched region length (%)   %ID
  --------------------- ----------------------------------------- ---------------------------- ------------------- ---------- ------------------------------ --------------------------- -----
  F31E8.1               Hypothetical protein                      AC05087.cl                   1                   1e -- 07   249                            14.5                        45
  F57B10.14             Hypothetical protein                      AE02023.cl                   2                   3e -- 20   56                             75.0                        69
  R10E9.3               Contains Cytochrome C heme-binding site   AC02329.cl                   1                   2e -- 10   149                            79.2                        32
                                                                  AE00556.cl                   2                   5e -- 19   149                            97.3                        31
  T07A9.13              Putative nuclear encoded protein          AE02236.cl                   1                   4e -- 31   111                            91.9                        49
  Y35H6.1               Hypothetical protein                      AE03902.cl                   1                   6e -- 23   161                            47.2                        48
  Y41C4A.3              Hypothetical protein                      AE00269.cl                   14                  1e -- 05   162                            49.4                        37
  Y54G2A.27             Hypothetical protein                      AC04390.cl                   1                   2e -- 05   229                            14.4                        38
                                                                  AE01938.cl                   9                   8e -- 07   229                            11.4                        48
  ZC487.3               Hypothetical protein                      AC04655.cl                   1                   2e -- 08   79                             81.0                        38
  ZK686.1               Nuclear transition protein                AC00867.cl                   16                  2e -- 07   44                             68.2                        62
                                                                  AE01651.cl                   3                   3e -- 07   44                             68.2                        62
  ZK84.5                Hypothetical protein                      AC00410.cl                   3                   6e -- 11   84                             70.2                        46

^a^Of 21,437 proteins 1,358 were candidate orphans

^b^AC, *Ancylostoma caninum;*AE, *A. ceylanicum*

Abundant transcripts expressed in *Ancylostoma*species
------------------------------------------------------

The 25 most abundantly represented clusters account for 14% and 19% of ESTs for *A. caninum*and *A. ceylanicum*respectively. The representation of the abundant transcripts varied from shared to stage-specific (Table [5](#T5){ref-type="table"} and Table [6](#T6){ref-type="table"}). Hookworm developmental stages differ in habitat, morphology and behavior, hence highly represented gene transcripts may identify functions that are important to the parasites at various stages. Differences in gene expression between *A. ceylanicum*stages have been demonstrated previously for several genes \[[@B27],[@B28]\]. Our comparison of iL3 and adult suggests additional examples (see Discussion). In fact, only 9% of the *A. ceylanicum*clusters are shared between iL3 and adult (Figure [2](#F2){ref-type="fig"}) and of the 25 largest clusters, 23 were biased toward one of the developmental stages (Table [6](#T6){ref-type="table"}). While representation in EST collections generally correlates with source expression level \[[@B29]\], artifacts can occur \[[@B30],[@B31]\]. Differences in expression are most likely to be accurate when comparing the most abundant transcripts in each stage. Therefore, while follow-up work is needed to confirm expression levels, examination of ESTs provides a list of candidates for various expression profiles.

Discussion
==========

Overview
--------

We have taken a genomics approach to the study of hookworm species, key parasites of humans and domestic animals that are related to the model nematode *Caenorhabditis elegans*. Nearly 20,000 ESTs from *Ancylostoma caninum*and *A. ceylanicum*identified approximately 7,000 genes including over 1,300 likely orthologs represented in both species. Close to 900 genes encode putative enzymes involved in 88 metabolic pathways. Over 3,100 genes contain recognizable protein domains many of which have been categorized in the Gene Ontology hierarchy. 4,600 genes have homologs in *C. elegans*including numerous nematode-specific genes and hundreds with observable RNAi phenotypes. ESTs originated from libraries representing infective L3 larva, stimulated L3, tissue arrested L3, and adults resulting in an improved rate of gene discovery and allowing the identification of transcripts abundant in various stages.

Gene expression in iL3 and dauers
---------------------------------

Infective L3 (iL3) are developmentally-arrested, non-feeding pre-parasitic stages, which when triggered by the infection process and host-specific signals reactivate, molt and complete development. A similar stage in *C. elegans*is called the dauer larva. In *Ancylostoma*species host factors such as dog serum stimulate feeding and an activation response in serum stimulated L3 (ssL3) \[[@B32]\] that approximates the transition to parasitism in the host \[[@B33]\]. *A. caninum*tissue-arrested L3 (taL3) recovered from infected mice are a distinct population that potentially share properties with the arrested iL3. Developmentally arrested, non-feeding larvae would be expected to be dependent on stored energy reserves and lipid metabolic pathways; accordingly, the KEGG biochemical pathway mappings show a substantive number of clusters for fatty acid metabolism especially with the *A. ceylanicum*iL3 clusters (Table [4](#T4){ref-type="table"}).

*C. elegans*microarray experiments identified 540 dauer-enriched genes along with genes involved in dauer-recovery \[[@B34]\]. *C. elegans*SAGE experiments identified 358 candidate dauer-specific genes \[[@B35]\]. Genes shown to be abundantly expressed in *C. elegans*dauers include a variety of genes that may play roles in extended survival including heat shock protein encoding genes like *hsp-12.6*and *daf-21*(Hsp90), *ctl-1*(cytosolic catalase), *sod-3*(superoxide dismutase), and *hil-1*and *hil-3*(Histone H1\'s). A number of genes identified both in *Ancylostoma*L3s and *C. elegans*dauers are discussed below.

### Heat-shock Proteins

hsp-12.6, a member of the *hsp-20*family, was one of the most highly represented clusters in *A. caninum*iL3 and taL3 as well as *A. ceylanicum*iL3 (Table [5](#T5){ref-type="table"} and Table [6](#T6){ref-type="table"}). Among a *Strongyloides stercoralis*EST collection, the gene is also found in iL3 but not L1 \[[@B17]\]. *C. elegans*hsp-12.6 is upregulated in dauer and starved L1s \[[@B34],[@B36]\] and is a transcriptional target of the FOXO transcription factor DAF-16 \[[@B37]\]. Unlike other HSPs, *C. elegans hsp-12.6*is not stress-induced and does not prevent aggregation of unfolded proteins, suggesting a novel role. AE00033.cl, found exclusively in adult ESTs, encodes an ortholog of the *Nippostrongylus brasiliensis*HSP-20 protein. *Nb-hsp-20*is more similar to the HSP-16 group of the HSP-20 family of small HSPs in *C. elegans*, is also expressed in the adult \[[@B38]\], and is not stress regulated, suggesting that it may function as an adult version of *hsp-12.6*.

### Candidate stress-response proteins

*A. caninum*iL3 showed abundant clusters encoding homologs of the mitochondrial cytochrome oxidase subunits I, II, III and a stress associated endoplasmic reticulum protein not seen in ssL3 (Table [5](#T5){ref-type="table"}). One *A. ceylanicum*iL3 abundant cluster encoded a ribosome-associated membrane 4 protein (RAMP4) involved in ER protein translocation \[[@B39]\] which is over-expressed in hypoxia and suppresses degradation of ER membrane proteins \[[@B40]\]. A homolog of *C. elegans spp-4*was also expressed at high levels in *A. ceylanicum*iL3. *spp-4*encodes an amoebapore, a member of the saposin-like protein superfamily that kill bacteria by forming membrane ion channels \[[@B41]\]. Amoebapore proteins are one of a number of putative stress response proteins regulated by DAF-16 in *C. elegans*\[[@B37],[@B42]\]. These proteins, also including lysozyme and thaumatin, may provide a defense against worm pathogens and contribute to dauer longevity \[[@B43]\]. Hookworm free-living stages are also soil dwelling microbiverous organisms exposed to soil pathogens, so it is possible that *spp-4*plays an antibacterial role in *A. ceylanicum*.

Gene expression in ssL3, adults, and multiple stages
----------------------------------------------------

In contrast to iL3, *A. caninum*ssL3 showed a CMP-sialic acid transporter, cathepsin D-like aspartic protease, calponin-like protein, and ham-2 zinc finger protein among the abundant transcripts. While the significance of these molecules is unknown, upregulation of an aspartic protease during the transition to parasitism and tissue penetration/migration is consistent with its role in degradation of serum proteins and collagens \[[@B44]\].

Abundant adult-specific clusters are likely to be involved in reproduction. For example, *A. ceylanicum*(Table [6](#T6){ref-type="table"}) encodes an ortholog of the *C. elegans*VIT-3 protein, a lipid binding protein and major yolk component \[[@B45]\]. VIT-3 is expressed exclusively in the *C. elegans*adult hermaphrodite intestine, secreted, and taken up by oocytes. Two clusters encode genes involved in metabolism of chitin, an important constituent of the nematode eggshell \[[@B46]\]. One encodes a protein similar to *C. elegans*protein C34D4.11, and shows some similarity to a beet chitinase; the other encodes an ortholog of *C. elegans*B0280.5, a protein required for early embryonic development \[[@B47]\]. B0280.5 mRNA is expressed specifically in the adult hermaphrodite germ line and is a target of GLD-1, an RNA binding protein required for oocyte meiotic cell cycle progression \[[@B48]\].

### ASP\'s

While there are differences in the cluster profiles among *Ancylostoma*stages, there are shared transcripts as well. For example, the *Ancylostoma*secreted protein ASP-1 and ASP-like cDNAs are present in abundance in both *A. caninum*iL3 and ssL3. The secretion of ASP-1 protein by ssL3s was noted as a marker of the transition to parasitism \[[@B12]\]. These results support conclusions made by Wang and Kim \[[@B34]\] that arrested larvae are transcriptionally prepared for dauer exit and upon receipt of appropriate stimulatory signals, exit from the arrested state is accompanied by a burst of translational activity in addition to further transcriptional activity. In contrast to ASP-1, ESTs for ASP-2 were exclusively detected in *A. caninum*iL3.

### FAR Proteins

Two of the most abundant *A. ceylanicum*transcripts encode fatty acid/retinol binding (FAR) proteins (Table [6](#T6){ref-type="table"}). FAR proteins are novel fatty acid and retinol binding proteins described in nematodes including *A. caninum*, other Strongylida, filarial, and plant parasitic species \[[@B49]-[@B51]\]. In *C. elegans*8 FAR members are divided into 3 groups. All the parasitic nematodes FARs described to date are most similar to the *C. elegans*A group containing *Ce-far-1*, -*2*, and -*6*. Seven *A. ceylanicum*clusters encode FAR proteins. Four of which (9 ESTs) were found in the adult cDNA library; clusters AE00748.cl and AE03203.cl were nearly identical to *Ac-far-1*and *Ac-far-2*(98% and 99% nucleotide identity) whereas cluster AE02490.cl showed the highest similarity to *Ce-far-1*and AE01700.cl to *Ac-far-2*. The iL3 specific clusters AE01410.cl (60/63 ESTs from iL3) and AE03983.cl (2/2 ESTs from iL3) were both most closely related to a FAR protein from *Ostertagia ostertagi*\[[@B52]\], and more distantly to *Ac-far-1*and *-2*. Therefore, as seen in other parasitic nematodes, most *A. ceylanicum*FAR proteins are related to *C. elegans*group A FAR proteins. However, the *A. ceylanicum*cluster AE00750 was most similar to group C FAR protein *Ce-far-7*. Group C proteins differ from the other FARs in important ways including lacking an N-terminal signal peptide (suggesting an intracellular location), containing several cysteines, and failing to bind DAUDA \[[@B53]\]. AE00750.cl represents the first report of a FAR-7 like protein from a parasitic nematode. The function of FAR proteins is unknown but may represent a lipid acquisition system in which released FARs bind to lipids followed by uptake of the complex by a specific receptor mediated process. Retinoids are required for nematode growth and development, but are not synthesized by the worms. In parasitic nematodes, release of FAR proteins may also modify local inflammatory and immunological responses by delivering or sequestering biochemically important lipids \[[@B54]\].

Conclusion
==========

The application of genomic approaches to hookworms has resulted in more than a 100-fold increase in available sequence data from *Ancylostoma*species thereby allowing an initial bioinformatic analysis of transcripts from these important parasites and establishing a foundation for the eventual completion of a hookworm genome. Semi-automated informatic approaches that are now being applied to all nematode sequences \[[@B55]\] allow uniform comparisons across many genomes and provide databases for further exploration. Transcripts in *A. caninum*and *A. ceylanicum*include clear candidates for stage specific expression representing the very different biological processes underway in different points of the lifecycle. The availability of the *C. elegans*and *C. briggsae*genomes has allowed highly informative comparisons to the two hookworm species showing extensive overlap in gene complements, including genes demonstrated to be essential in *C. elegans*and numerous genes specific to nematodes. As the most closely related major human pathogen to *C. elegans*, hookworms provide an attractive near-term application for using a model organism to better understand and eventually control a key disease-causing species. Beyond categorization of hookworm genes, clear research avenues are available to apply this information to improved methods for hookworm control including anthelmintic and vaccine development, diagnostics, population studies, as well as better understanding of fundamental aspects of hookworm biology, such as host immune system modulation.

Methods
=======

Nematode extraction
-------------------

A Shanghai strain of *A. caninum*was maintained in beagles as described \[[@B56]\]. Infective L3 (iL3) were recovered from 7--10 day old coprocultures using a modified Baermann technique, washed clean of debris with BU buffer (50 mM Na~2~PO~4~/22 mM KH~2~PO~4~/70 mM NaCl, pH 6.8; \[[@B57]\]), and snap-frozen by immersion in liquid N~2~. Frozen larvae were stored at -80°C until used for library construction. Serum stimulated larvae (ssL3) were generated by incubating iL3s harvested from a North Carolina strain of *A. caninum*in 5% normal dog serum for 20--24 h at 37°C, 5% carbon dioxide. Tissue-arrested L3 larvae (taL3) were recovered from BALB/c mice infected with 1,000--1,500 iL3 (North Carolina strain) and euthanized at 10--14 days post-infection \[[@B58]\].

A Warsaw strain of *A. ceylanicum*was maintained in Syrian hamsters as described \[[@B59]\], and L~3~recovered, washed, and frozen as above. For the recovery of adult stage *A. ceylanicum*, infected hamsters with patent infections were sacrificed and the small intestine removed. The intestine was cut into 3 sections, opened longitudinally, and hung in 50 ml centrifuge tubes containing phosphate buffered saline at 37°C for 2--3 hrs. Following incubation, adult worms were recovered from the sediment, washed free of debris, and snap-frozen as above. All animals were housed and treated in accordance with institutional care and use committee guidelines.

Preparation of *A. caninum*staged RNA and cDNA libraries
--------------------------------------------------------

Pulverization for the ssL3 and taL3 was performed using an Alloy Tool Steel Set (Fisher Scientific International). Total RNA from adult and larval parasites was prepared using TRIzol Reagent (GibcoBRL, Life Technologies or Invitrogen, Carlsbad, CA).

SMART based serum stimulated L3 library -- Library construction was based on the SMART cDNA library construction system (Clontech Laboratories; \[[@B60]\]). mRNA was extracted from 10 μg of total RNA using a Dynabeads mRNA Purification kit (Dynal Biotech) with some modifications. First strand synthesis was performed with the mRNA bound to the oligo-dT of the Dynabeads using Superscript II RT (Invitrogen, Life Technologies) and the primer smart T7_3G_5. Concatemers were digested with Not I on the bead. Second strand synthesis was performed with the smartT7_5 and the smartCDSII primer. Amplification of the cDNA was performed with the smartT7_5 and smartT7_3 primers with cycling parameters of 95°C for 5 minutes, seven cycles of 95°C for 5 seconds, 60°C for 5 seconds and 68°C for 6 minutes followed by a 4 minute extension at 68°C. Following amplification, the cDNA was purified using the High Pure PCR Product Purification Kit (Roche). The final 5 cycles of PCR introduced the deoxy-UMP primers needed for cloning into the pAMP1 vector (Invitrogen, Life Technologies). cDNA fragments \>1 kb were size selected on a 0.8% TAE agarose gel and cloned into the pAMP1 vector following the CloneAMP pAMP1 System (Invitrogen, Life Technologies). The ligation mix introduced into *E. coli*DH10B chemically competent cells (GibcoBRL, Life Technologies) resulted in 4.36 × 10^5^primary transformants.

SL1-PCR-based tissue arrested L3 library -- mRNA was extracted from 2 μg of total RNA using a Dynabeads mRNA Purification kit (Dynal Biotech) and eluted with 10 μl 10 mM Tris-HCl. First strand synthesis was performed using linker primer (GAGAGAGAGAGAGAGAGAGAACTAGTCTCGAGTTTTTTTTTTTTT) and Superscript II RT (Invitrogen, Life Technologies). Amplification with Taq Polymerase used the SL1 (GGGTTTAATTACCCAAGTTTGA) and Xhop (GAGAGAGAACTAGTCTCGA) primers and 5 μl of the first strand reaction. Cycling parameters were 95°C for 5 minutes, 30 cycles of 95°C for 1 minute, 47°C for 1 minute, 72°C for 3 minutes followed by 5 minutes at 72°C. cDNA fragments \>1 kb were size selected on a 0.8% TAE agarose gel and cloned into the pCRII-TOPO vector following the TOPO TA protocol (Invitrogen). The ligation mix was introduced into *E. coli*DH10B chemically competent cells (GibcoBRL, Life Technologies).

Hawdon infective L~3~library -- Frozen *A. caninum*L3 pellets were ground to powder on a mortar pre-chilled with liquid nitrogen. Total RNA was isolated from the powder using Trizol reagent (Invitrogen, Carlsbad, CA). Poly (A)+ RNA was isolated from total RNA using the Oligotex mRNA isolation kit (Qiagen, Chatsworth, CA). Approximately 5 μg of mRNA was used to construct a directional cDNA library in Lambda ZAP II (Stratagene, La Jolla, CA) as previously described \[[@B61]\]. pBluescript phagemid were mass excised prior to sequencing. The library had \>95% recombinants, and insert size varied from 700--3,000 bp. The library was amplified once (10^6^pfu).

Preparation of *A. ceylanicum* staged RNA and cDNA libraries
------------------------------------------------------------

Hawdon adult and infective L3 *A. ceylanicum*libraries -- Total RNA and poly (A)+ mRNA were isolated from the appropriate *A. ceylanicum*life-cycle stage using Trizol reagent and the Oligotex mRNA isolation kit as described above. Approximately 5 μg of mRNA was used to construct directional cDNA libraries in Lambda ZAP II (Stratagene, La Jolla, CA) as previously described \[[@B61]\]. Both libraries had 99% recombinants with inserts ranging from 500--2500 bp (average 1500 bp), and each underwent one round of amplification (10^6^pfu). Inserts were mass excised as described above.

SL1-PCR-based infective L3 and adult libraries -- cDNA was PCR amplified, using SL1-EcoRI primer on the 5\' end and oligo(dT)-XhoI on 3\' end, gel fractionated \[[@B62]\], and non-directionally cloned into pCR-TOPO-XL (Invitrogen), following XL-Topo TA cloning protocol. The cDNA inserts were excised with EcoRI.

Sequencing and clustering
-------------------------

Sequencing, EST processing and clustering were performed as described \[[@B17]\]. Information for clone requests and sequence trace files are available at <http://www.nematode.net>. The completed cluster assemblies, NemaGene *Ancylostoma caninum*v 2.0 and *A. ceylanicum*v 2.0, were used as the basis for all subsequent analyses and are available for searching and acquisition by FTP at <http://www.nematode.net>. \"Fragmentation\", defined as the representation of a single gene by multiple non-overlapping clusters, was estimated by examining *Ancylostoma*clusters with homology to *C. elegans*\[[@B17]\]. Overall representation of *Ancylostoma*genes is based on a theoretical gene number of 21,437, comparable to *C. elegans*wormpep97.

Analysis and functional assignments
-----------------------------------

Homology assignments -- WU-BLAST sequence comparisons \[[@B63],[@B64]\] were performed using *A. caninum*and *A. ceylanicum*contig consensus sequences which were further organized into clusters. Consensus sequences were used to search multiple databases, including the non-redundant GenBank (3/20/2003) and Wormpep v.97 *C. elegans*(Wellcome Trust Sanger Institute, unpublished) protein databases. Internally constructed databases using intersections of data from Genbank, allowed examination of sequences in specific phylogenetic distributions. Homologies were reported for E (expect) value scores of ≥ 1e -05.

To identify cases where *Ancylostoma*homologs in *C. elegans*have been surveyed for knock-down phenotypes using RNA interference, Wormpep BLAST matches were cross-referenced to a list of 17,042 *C. elegans*genes with available RNAi information (20^th^February 2005) <http://www.wormbase.org>. For each *Ancylostoma*cluster, only the best *C. elegans*match was considered.

Functional classification -- Clusters were assigned putative functional categorization using two methods. First, InterProScan v.3.1 <ftp://ftp.ebi.ac.uk/pub/software/unix/iprscan> was used to search contig translations versus InterPro domains (11/08/02) \[[@B65],[@B66]\]. Using InterPro, clusters were mapped to the three organizing principles of the Gene Ontology (GO_200211_assocdb.sql) \[[@B67]\]. Mappings are stored by MySQL database, displayed using AmiGo (11/25/02) <http://www.godatabase.org/cgi-bin/go.cgi>, and are available at <http://www.nematode.net>. Second, clusters were assigned by enzyme commission number to metabolic pathways using the Kyoto Encyclopedia of Genes and Genomes (KEGG) database (2/24/2004)\[[@B68]\]. All matches better than 1e-10 were taken into consideration.

Orthologs and dN/dS ratio -- *A. caninum*/ *A. ceylanicum*orthologs were determined by reciprocal best TBLASTX match using a threshold of E value ≥ 10^-5^. In addition, the ORFs accepted to be the correct translation were required to have the best *C. elegans*gene match in the same frame as the TBLASTX matches. Only continuous alignments longer than 30 amino acids were accepted. \'Suboptimal alignment program\' (Jason Stajich, unpublished), scripted using tools in Bioperl \[[@B69]\] and utilizing \'yn00\' from PAML \[[@B70]\], calculated the synonymous (dS) and non-synonymous substitutions (dN) per ortholog pair. A 4-way orthologs were assigned by using SSEARCH \[[@B71],[@B72]\] to find the best *C. elegans*and *C. briggsae*homolog for each ortholog pair of *A. caninum*and *A. ceylanicum*. Orthologs were assigned if both sequences agreed on the best hits. Multiple sequence alignments were performed with MUSCLE \[[@B73]\]. Trees were built using the programs \'protml\' and \'nucml\' for protein and nucleotide sequences respectively \[[@B26]\]. An exhaustive search was used first to enumerate the possible topologies and then -R rearrangement search was used to identify the most likely branch lengths and bootstrap values. Only genes for which well supported topologies where *A. caninum*and *A. ceylanicum*appeared as sisters were used in subsequent analysis. Tree branch lengths were parsed and processed with Perl scripts written using modules from the Bioperl package and statistical tests were applied with the R package \[[@B74]\].
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